SLC31A1 and neoplasm: In a cohort of NSCLC patients with neoadjuvant platinum-based chemotherapy, Kim et al. reported that the African American had significantly reduced SLC31A1 expression in tumor, lowered tissue platinum concentration and decreased tumor shrinkage as compared to Caucasians 6.